InsiderTrades

Form 4 for NOMD Nomad Foods Ltd

Accepted 2026-05-08 16:45:41 ET · period of report 2026-05-06 · accession 0000940603-26-000007 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DMI 2026-05-08 16:45 2026-05-06 NOMD FRANKLIN MARTIN E Dir, Co-COB J - Other $0.00 0 7.44M New $0
D 2026-05-08 16:45 2026-05-07 NOMD FRANKLIN MARTIN E Dir, Co-COB A - Grant $0.00 +1.00M 1.00M New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Ordinary Shares 2026-05-06 J D 220,000 $0.00 3,321,251 I BY RSMA, LLC — — (F1) 220,000 shares previously reported as held indirectly by RSMA, LLC, of which Mr. Franklin is the managing member, were transferred to the Martin E. Franklin Revocable Trust (the "Franklin Trust") for estate planning purposes. (F2) These Ordinary Shares are held by directly by RSMA, LLC, of which Mr. Franklin is the managing member. Mr. Franklin disclaims beneficial ownership of any shares except to the extent of his pecuniary interest therein.
2 Common Ordinary Shares 2026-05-06 J A 220,000 $0.00 7,442,212 I By the Martin E. Franklin Revocable Trust — — (F1) 220,000 shares previously reported as held indirectly by RSMA, LLC, of which Mr. Franklin is the managing member, were transferred to the Martin E. Franklin Revocable Trust (the "Franklin Trust") for estate planning purposes. (F4) These Ordinary Shares are held by the Martin E. Franklin Revocable Trust, of which Mr. Franklin is the sole settlor, trustee and beneficiary. Mr. Franklin disclaims beneficial ownership of any shares except to the extent of his pecuniary interest therein.
3 Derivative Stock Options (Right to Buy) 2026-05-07 A A 1,000,000 $0.00 1,000,000 D $10.14 · — to 2031-05-07 1,000,000 Ordinary Shares (F5) Subject to (i) the Reporting Person satisfying the share purchase component under the Issuer's Co-Investment and Share Option Matching Sub Plan (the "Sub Plan") between May 5, 2025 and June 5, 2027 and (ii) the Issuer's achievement of the share price performance target during the period beginning May 7, 2026 and ending on May 7, 2031 (the "Performance Period"), the Options will vest and become exercisable, if at all, on the later of (x) May 7, 2029 and (y) the achievement of the specified share price performance target during the Performance Period.